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Cell type specification relies on the capacity of undif-
ferentiated cells to properly respond to specific dif-
ferentiation-inducing signals. Using genomic ap-
proaches along with loss- and gain-of-function
genetic models, we identified OCT4-dependent
mechanisms that provide embryonic stem cells
with the means to customize their response to
external cues. OCT4 binds a large set of low-acces-
sible genomic regions. At these sites, OCT4 is
required for proper enhancer and gene activation
by recruiting co-regulators and RAR:RXR or b-cate-
nin, suggesting an unexpected collaboration be-
tween the lineage-determining transcription factor
and these differentiation-initiating, signal-dependent
transcription factors. As a proof of concept, we
demonstrate that overexpression of OCT4 in a kidney
cell line is sufficient for signal-dependent activation
of otherwise unresponsive genes in these cells. Our
results uncover OCT4 as an integral and necessary
component of signal-regulated transcriptional pro-
cesses required for tissue-specific responses.
INTRODUCTION
One of the major challenges of developmental cell biology is to
understand the mechanisms that underlie cell type-specific dif-
ferential gene expression. Embryonic stem cells (ESCs) repre-
sent an excellent model system for studying how the transcrip-
tional output of a given cell type is controlled by distinct
combinations of transcription factors under the control of
extrinsic signals. ESCs can be maintained in a ‘‘naive pluripotent
state’’ (serum + leukemia-inhibiting factor [LIF]) or in a ‘‘ground
state of pluripotency’’ (2 inhibitor [2i]) (Nichols and Smith,Mo2009), conditions under which these cells have a unique gene
expression program and regulatory chromatin landscape that al-
lows them to self-renew yet remain capable of differentiating into
any cell type (Guo et al., 2016a, 2016b; Kolodziejczyk et al.,
2015; Kumar et al., 2014; Nichols and Smith, 2009; Young,
2011). The POU family homeodomain transcription factor
OCT4 (also known as POU5F1) is an indispensable component
of this regulatory circuitry (Hay et al., 2004; Ivanova et al.,
2006; Loh et al., 2006; Nichols et al., 1998; Niwa et al., 2000;
Okamoto et al., 1990).
To understand the transcriptional regulatory network in
ESCs, genome-wide studies were conducted to determine
the OCT4 cistrome (the genomic binding sites of OCT4) (Boyer
et al., 2005, 2006; Chen et al., 2008; Kim et al., 2008; Lee et al.,
2006; Liang et al., 2008; Loh et al., 2006; Morey et al., 2015).
Recent studies revealed a substantial reorganization of OCT4
occupancy between ‘‘naive’’ or ‘‘ground state’’ (pre-implanta-
tion) versus ‘‘primed’’ (post-implantation) stem cell states, sug-
gesting that the engagement of OCT4 with the genome is dy-
namic and context-dependent in early differentiation (Buecker
et al., 2014; Factor et al., 2014; Yang et al., 2014). These re-
sults, along with additional evidence, suggest that OCT4 is
likely involved in early cell fate determination as well (Frum
et al., 2013; Funa et al., 2015; Niwa et al., 2000; Radzisheus-
kaya et al., 2013; Yang et al., 2014). However, it is not known
how it might contribute to signal-specific differentiation events,
if at all.
Depending on the signals provided, ESCs can differentiate
into a variety of cell types (Wobus and Boheler, 2005). LIF/
STAT3, WNT/b-catenin, and bone morphogenetic protein
(BMP)/SMAD have been suggested as context-dependent regu-
lators of both ESC self-renewal and differentiation (Chatterjee
et al., 2015; Funa et al., 2015; Itoh et al., 2014; Niwa et al.,
1998; Zhang et al., 2013). In contrast, retinoic acid (RA) is known
as an efficient inducer of ESCdifferentiation (Gudas andWagner,
2011; Rochette-Egly, 2015; Simandi et al., 2010).
RA acts through binding to the heterodimer of retinoic acid re-
ceptor (RAR) and retinoid X receptor (RXR) (Chambon, 1996;lecular Cell 63, 647–661, August 18, 2016 ª 2016 Elsevier Inc. 647
Figure 1. OCT4 Occupies Low-Accessible Genomic Regions
(A) Read distribution heatmap of OCT4 and H3K27ac ChIP-seq and DNase-seq reads (±1 kb, relative to the summits of the detected OCT4 peaks). The black
dotted line marks the detection threshold of highly accessible regions predicted from DNase-seq. See also Table S1.
(B) Canonical upstream regulators in the activation of OCT4+/DNase low regions as predicted by Ingenuity.
(C) Integrative Genomics Viewer (IGV) snapshot of enhancers in the proximity of pluripotency-related (Oct4, Nanog, and Esrrb) or differentiation-related genes.
Distances of the enhancers from the TSS of the indicated genes are shown.
(D) Read distribution heatmap of OCT4 ChIP-seq obtained in cells grown under 2i + LIF (ground state) versus serum + LIF (naive) culture conditions. OCT4+/
DNase low sites are compared (see A).
(E) ChIP-qPCR analysis of OCT4 binding at the indicated enhancers.
(F) Western blot assay showing expression of OCT4 in total extracts from untransfected cells (Mock) or cells transfectedwith non-specific (siNeg) orOct4-specific
siRNAs (siOct4 A and siOct4 B). Samples were collected 24 hr following transfection.
(G) qRT-PCR analysis of Nanog at the mRNA level 24 hr after RNAi transfection.
(legend continued on next page)
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Giguere et al., 1987). These nuclear receptors bind to cis-acting
retinoic acid response elements (RAREs) in the regulatory region
of their target genes (Chatagnon et al., 2015; Cunningham and
Duester, 2015). According to canonical models, RAR:RXR re-
ceptors are bound by the nuclear receptor co-repressor
silencing mediator of retinoic acid and thyroid hormone receptor
(SMRT) and histone deacetylase 3 (HDAC3) in the absence of
ligand and keep the target genes repressed (Nagy et al., 1999).
Ligand binding induces a structural change that will initiate the
exchange of these co-repressors for co-activators, such as the
histone acetyltransferase P300.
WNT/b-catenin signaling is a highly conserved signaling
pathway that supports the pluripotency of ESCs but also pro-
motes early developmental processes (Lindsley et al., 2006;
ten Berge et al., 2011; Zhang et al., 2013). In the absence of
WNT, b-catenin is phosphorylated by GSK-3, which tags it for
proteosomal degradation. Activation of WNT signaling with the
GSK-3 inhibitor CHIR99021 has been shown to have pleiotropic
effects, promoting non-neural differentiation, suppressing neural
differentiation, and enhancing growth capacity (Merrill, 2012;
Nichols et al., 2009; Ying et al., 2008).
Here we performed an unbiased and comprehensive anal-
ysis of OCT4 functions in signal-induced ESC differentiation.
Analysis of genome-wide OCT4 occupancy in the context of
the chromatin state revealed binding of OCT4 to regions
with low DNA accessibility. We demonstrate that such
OCT4-mediated binding events are priming a distinct set of
enhancers to respond to external cues, such as retinoic acid
and WNT. Mechanistically, RAR:RXR shares a subset of
OCT4-occupied enhancers, and OCT4 also occupies en-
hancers that are activated by the canonical WNT/b-catenin
signal. Consequently, removal of OCT4 dysregulates the in-
duction of RA or WNT target genes and affects subsequent
lineage specifications.
This study provides insights into the transcriptional regulation
of cell fate by highlighting the direct links, interdependence, and
multi-level collaborative connections between lineage-deter-
mining (OCT4) and signal-dependent (RAR:RXR or b-catenin)
transcription factors.
RESULTS
OCT4 Occupies Low-Accessible Genomic Regions in
Undifferentiated ESCs
Previous studies revealed the existence of active and poised
enhancers in various model systems, suggesting that en-
hancers contain information not only about the current state
of the cell but its future developmental potential as well (Boyer
et al., 2006; Creyghton et al., 2010; Factor et al., 2014; Heinz
et al., 2015; Rada-Iglesias et al., 2011). To determine whether
OCT4 contributes to subsequent developmental stages or re-
sponds to external cues by marking or priming lineage-specific(H) Heatmap displays of microarray data (re-analyzed from Loh et al., 2006) show
depleted cells versus the parental controls.
(I) qRT-PCR analysis of mRNA levels of selected retinoid target genes in OCT4-de
ratio of the indicated genes’ transcript relative to 36b4.
See also Figure S1. ns, non-significant. *p% 0.05, **p% 0.01, ***p% 0.001.enhancers, we first delineated the OCT4 cistrome by chro-
matin immunoprecipitation sequencing (ChIP-seq) in mouse
ESCs. We identified 21,000 genomic regions enriched for
OCT4 in naive ESCs (Figure 1A). Motifs found in these loci
were a perfect match to the previously identified elements in
stem cells, including the OCT4-SOX2 composite element,
NANOG, and SOX2 binding sites (Figure S1A). To assess
whether all OCT4 binding sites overlap with active, highly
accessible genomic regions, we generated chromatin state
maps for H3K27ac (histone 3 lysine 27 acetylation) enrichment
and also analyzed DNase hypersensitive sites. A major fraction
of OCT4 binding (>40%) was associated with regions charac-
terized by H3K27ac-negative chromatin and lower DNase
accessibility (termed OCT4+/DNase low) (Figure 1A). Similarly,
OCT4 also occupied low-accessibility sites in ground state plu-
ripotency (Figure S1B). Motif analysis revealed that while the
‘‘OCT4+/DNase high’’ regions determined in Figure 1A were
enriched for the binding motif of NANOG and KLF4 in addition
to OCT4 and SOX2 elements, the ‘‘OCT4+/DNase low’’ regions
were only significantly enriched for OCT4 (Figure S1C), sug-
gesting that the low-accessible regions are regulated indepen-
dently of NANOG and KLF4. Pathway analysis of genes linked
to the OCT4+/DNase low regions revealed that many of these
sites are targets for WNT/b-catenin and RA signaling (Fig-
ure 1B). In line with this, targets of WNT/b-catenin (e.g.,
Wnt3 and T/Brachyury) and RAR:RXR (e.g., Hoxa1, Prmt8,
Cdx2, and Pmp22) showed OCT4 enrichment but low chro-
matin accessibility in their proximity (Figure 1C). These sites
were enriched for the repressive histone mark H3K27me3 (his-
tone 3 lysine 27 trimethylation) but not for H3K27ac. OCT4
binding was generally weaker at these sites (Figure S1D).
Comparison of OCT4 binding in naive cells (serum + LIF)
versus cells grown under defined culture conditions (2i + LIF)
revealed that Oct4 is already present on these sites in ground
state pluripotency (Figures 1C–1E).
To investigate the biological relevance of OCT4 binding to
these low-accessible genomic regions in the proximity of
RAR:RXR and WNT/b-catenin target genes, we examined the
expression changes of RA and WNT targets upon OCT4 deple-
tion. Small interfering RNA (siRNA) knockdown of OCT4 did
not affect most of the studied differentiation markers, including
the WNT/b-catenin targets (Figures 1F–1H; Figure S1E). In
contrast, a subset of early retinoid target genes showed elevated
basal mRNA expression (Figures 1H and 1I; Figures S1F and
S1G). The depletion of OCT4 had no effect on the expression
levels of some retinoid target genes (e.g., Cyp26a1 and Dleu7)
(Figures 1H and 1I), suggesting that OCT4 selectively contributes
to the regulation of retinoid-regulated genes. Importantly, loss of
NANOG did not influence the expression of the OCT4-depen-
dent RA target genes (Figure 1H), confirming that this regulation
is independent of other members of the canonical pluripotent
network.ing expression changes of RA- or WNT-regulated genes in NANOG- or OCT4-
pleted cells 24 hr after transfection. Gene expression data are expressed as a
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OCT4 Maintains Rarg Expression in Pluripotent Cells,
and a Subset of Retinoid Target Genes Are Co-occupied
by OCT4/RAR:RXR
To understand how OCT4 controls RA signaling in ESCs, we
compared the expression levels of the RA pathway components
in control versus OCT4-depleted cells. Immunostaining con-
firmed the presence of RAR in ESCs (Figure S2A). OCT4 knock-
down did not affect Aldh1a1-3, Stra6, and Crabp2 levels (Fig-
ure 2A), suggesting that OCT4 does not control RA transport or
synthesis per se. However, the major RAR isoform in ESCs,
Rarg, was significantly reduced upon OCT4 depletion, suggest-
ing that OCT4 positively controls its level in pluripotent cells
(Figures 2A and 2B). We identified OCT4 binding on a canonical
motif in a conserved, highly acetylated intronic region of Rarg
(Figures 2C and 2D; Figure S2B). The activity of this enhancer
was similar in naive versus ground state pluripotent cells (Fig-
ure 2E), but we could detect a reduced level of enhancer tran-
script in the absence of OCT4 (Figure 2F), further supporting
the notion that OCT4 positively controlsRarg expression through
this enhancer. As a consequence of OCT4-depletion and
decreased RAR expression, downstream target genes of Rarg
also showed decreased expression (Figure 2G; Al Tanoury
et al., 2014).
Next we studied whether OCT4 modulates RA signaling at the
enhancer level as well. We used ChIP-seq to monitor the
genome-wide binding profiles of OCT4 and RXR, the obligate
heterodimeric partner of RAR (Kliewer et al., 1992). This analysis
revealed that more than 1,200 genomic regions were co-occu-
pied by both OCT4 and RXR (termed ‘‘common’’) (Figure 2H).
Conversely, a large fraction of the RXR-bound sites lacked
OCT4 (‘‘RXR only’’), suggesting the existence of both OCT4-
associated and OCT4-independent RXR-bound enhancers.
Transcription factor binding motifs present among the genomic
loci shared by OCT4 and RXR revealed enrichment for both
OCT4 and the nuclear receptor response elements (nuclear re-
ceptor [NR] half) (Figure S2C), indicating that these transcription
factors might cooperate in DNA binding. Indeed, OCT4 (but not
NANOG, KLF4, or SOX2) and RAR:RXR were found to be over-
lapping in close proximity of several retinoid-regulated genes
both in the ground state and naive state (Figure 2I; Figures
S2D and S2E). ChIP-chromatin re-immunoprecipitation (reChIP)
experiments confirmed that RAR:RXR and OCT4 are binding
simultaneously to these sites in the same cells (Figure 2J; Fig-
ure S2F). OCT4 binding could not be detected in the proximity
of retinoic acid target genes that were unaffected at the mRNA
level in OCT4-depleted cells (e.g.,Cyp26a1 andDleu7), suggest-
ing that these genes are regulated by OCT4-independent,
RAR:RXR-bound enhancers (Figure 2I; Figure S2D).
To address whether OCT4 binding to the RAR:RXR-occupied
enhancers in the proximity of retinoic acid target genes is
required for their repression, we measured enhancer transcripts
at these sites in OCT4-depleted cells. Enhancers co-occupied
by OCT4 and RAR:RXR showed increased enhancer RNA
(eRNA) production, whereas loss of OCT4 had no effect on the
Cyp26a1 enhancer (Figure 2K; Figure S2G). Taken together,
these results indicated a gene- and enhancer-specific negative
regulation of retinoid signaling by OCT4 both in naive and ground
state ESCs.650 Molecular Cell 63, 647–661, August 18, 2016Co-regulators Are Selectively Recruited to
OCT4-Containing RXR Sites
OCT4-mediated repression of retinoid signaling raises the ques-
tion of whether this repressive function ismediated through inter-
actions with known nuclear receptor co-repressors such as
SMRT and HDAC3 (Cunningham and Duester, 2015; Jepsen
et al., 2007; Urvalek and Gudas, 2014). Genome-wide analysis
of the SMRT and HDAC3 cistrome by ChIP-seq highlighted
several binding motifs for pluripotency-associated transcription
factors, but no canonical binding sites for nuclear receptors
were found (Figure S3A). The co-activator P300 also showed
similar motif enrichment (Figure S3B), suggesting that primarily
OCT4, rather than RAR:RXR, recruits these co-regulators in
stem cells. Further interrogation of the genome-wide distribution
of P300, SMRT, and HDAC3 in ESCs demonstrated that only
sites co-occupied by OCT4/RAR:RXR are bound by these co-
factors, and none of these co-regulators were detected at RXR
only sites (e.g., Cyp26a1 1.8 kb) (Figures 3A and 3B).
To establish whether OCT4 is indeed required for co-factor
recruitment, we depleted OCT4 and examined RAR:RXR,
P300, SMRT, and HDAC3 binding at candidate loci representa-
tive of the OCT4-RXR co-occupied (common) regions (the
regions are shown in detail in Figure S3C). Depletion of OCT4 re-
sulted in decreased co-regulator occupancy (Figure 3C) without
affecting their total protein levels (Figure 3D).
Co-occupancy of co-repressors and co-activators at the
same genomic regions was somewhat surprising. ChIP-reChIP
experiments confirmed that P300 and HDAC3 are present on
the same genomic regions in the same cells (Figure 3E; Fig-
ure S3D). Loss of HDAC3 selectively enhanced H3K27ac and
mRNA levels of OCT4/RAR:RXR targets but did not change the
acetylation status of the control Cyp26a1 enhancer or its
mRNA expression (Figure 3F; Figure S3E). These findings sup-
port the co-existence of acetyltransferases and deacetylases
at the OCT4/RAR:RXR co-occupied sites and their function in
the maintenance of chromatin accessibility.
OCT4 Binding Shifts in Response to RA Exposure
We next focused on characterizing OCT4’s involvement in the
early events of RA-induced ESC differentiation. Oct4 mRNA
was substantially repressed by RA 24 hr post-treatment (Fig-
ure 4A). However, at the protein level, OCT4 was more stable
and could still be detected 72 hr after RA addition (Figure 4B).
As Figure 4C indicates, approximately half of the sites displayed
OCT4 binding only in untreated ESCs (‘‘ES-specific’’). A large
number of sites showed similar enrichment levels in both un-
treated and RA-treated cells (‘‘constitutive’’). Strikingly, we could
also identify2,000 sites occupied byOCT4 only in the presence
of RA (‘‘RA-induced’’). Genes previously linked to pluripotency
(e.g., Otx2, Tdh, and Foxd3) (Shyh-Chang et al., 2013) showed
a loss of OCT4 binding, whereas retinoid target genes typically
showed constitutive or RA-induced OCT4 binding (Figure 4D).
RA signaling is known to play an important role in determining
the anterior boundary of Hox gene expression in the neural tube
during embryogenesis (Mallo et al., 2010). Based on our
H3K27ac, RXR, and OCT4 ChIP-seq data, we found that the
RARE located +5 kb from the transcription start site (TSS) of
Hoxa1 (Kashyap et al., 2011; Langston and Gudas, 1992) and
Figure 2. OCT4 Regulates Rarg Expression
(A) Heatmap display ofmicroarray data showing expression changes of RA signaling-related genes affected byOCT4 depletion. Themicroarray data are from Loh
et al. (2006). ctrl, control.
(B) IGV snapshot of RNA-seq data showing expression levels of RXR and RAR receptor isoforms in undifferentiated ESCs.
(C) IGV snapshot of the Rarg locus showing the OCT4 and H3K27ac ChIP-seq profiles.
(D) ChIP-qPCR analysis of OCT4 enrichment at the enhancer depicted in (C). IgG, immunoglobulin G.
(E) qRT-PCR analysis of Rarg +14 kb enhancer activity (eRNA production) from cells grown under 2i + LIF versus serum + LIF conditions.
(F) eRNA production of Rarg +14 kb enhancer 24 hr following OCT4-depletion.
(G) qRT-PCR analysis of Rarg downstream target genes following OCT4 depletion.
(H) Read distribution heatmap of OCT4 and RXR ChIP-seq reads (serum + LIF) relative to the midpoint of their enrichments. See also Table S2.
(I) IGV snapshot of ChIP-seq data.
(J) ChIP-reChIP analysis of OCT4 and RAR co-occupancy. The first ChIP was carried out using anti-RAR antibody. Antibodies against IgG, OCT4, or RAR were
used for the reChIP.
(K) qRT-PCR analysis of eRNA levels in OCT4-depleted cells. Cells were collected for RNA isolation 24 hr after RNAi transfections. Data are expressed as a ratio of
the indicated enhancer’s transcript relative to 36b4.
See also Figure S2. *p% 0.05, **p% 0.01, ***p% 0.001.
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Figure 3. OCT4-Dependent Co-regulator Enrichment on RAR:RXR-Bound Enhancers
(A) Density of RXR, OCT4, P300, SMRT, and HDAC3 ChIP-seq reads relative to the summit of the RXR peaks (±1 kb).
(B) IGV snapshot of the indicated ChIP-seq data at enhancers driven by RXR heterodimers (LXR:RXR: Srebf1, Fasn, Abca1; RAR:RXR: Pmp22-Cyp26a1).
(legend continued on next page)
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two additional enhancers in close proximity of Hoxa1 (+51 kb
and + 79kb from the TSS) are prototypical examples of constitu-
tive OCT4-bound enhancers (Figure 4E). Strikingly, P300 was
occupied at these sites prior to RA induction, further supporting
the concept that these sites are primed for signal-dependent
activation (Figure 4E). This P300 binding was completely dimin-
ished in OCT4-depleted cells (Figure 4F; Figure S4A). Increased
H3K27ac and enhancer RNA production confirmed that all of
these enhancers are indeed RA-inducible (Figures 4E and 4G).
Detection of OCT4 occupancy at different time points
following RA treatment revealed a stable OCT4 enrichment up
to 48 hr (Figure 4H; Figure S4B), suggesting that OCT4 binds
concurrently with activated RAR:RXR.
Gene ontology analysis of genes linked to enhancers showing
constitutive or RA-induced OCT4 binding revealed that these
sites are essential for normal embryonic and nervous system
development (Figure S4C). To understand whether a newly pro-
duced protein is responsible for the OCT4 redistribution (Fig-
ure 4C), we carried out de novo motif analysis on these RA-
induced sites. Over 20% of RA-induced OCT4 regions showed
enrichment for Pbx-Hox-like motifs (Figure 4I). Analysis of the
RA response in Hoxa1 KO cells (Martinez-Ceballos et al., 2005)
revealed that HOXA1 is indeed involved in the regulation of these
sites (Figures S4D–S4F).
Together, these data demonstrate that at a subset of regions
of Hoxa1 promotes OCT4 recruitment to new sites and regulates
enhancer activity.
OCT4 Directly Regulates Retinoic Acid and WNT/
b-Catenin Signaling and Downstream Differentiation
Pathways
The prolonged presence (48 hr following the signal-dependent
activation) of OCT4 at differentiation-related enhancers sug-
gests that OCT4 might also play a role in the on-time activation
of these sites and the induction of corresponding regulated
genes. To explore this possibility, we characterized RA
and WNT/b-catenin signaling pathways, predicted in Figure 1B
as putative activators of the low-accessible OCT4-occupied
sites. Cistromic analysis of RXR upon activation by RA and
b-catenin binding following treatment with the GSK-3 inhibitor
CHIR99021 revealed the enrichment of these signal-dependent
transcription factors at a subset of OCT4+/DNase low sites
(Figures 5A and 5B). To understand how OCT4 contributes to
signal-dependent activation of these enhancers, we compared
eRNA production at OCT4/RAR:RXR and OCT4/b-catenin co-
occupied regions upon signal-specific activation. Activity of
the identified RA-driven Hoxa1 enhancers and the WNT/b-cate-
nin-activated T/Bra or Tfcp2l1 enhancers showed absolute
OCT4-dependence (Figure 5C; Figure S5A). However, we also
identified enhancers that showed an increased response in(C) ChIP-qPCR analysis of RXR, OCT4, SMRT, HDAC3, and P300 binding at Gre
(siNeg) or OCT4-depleted (siOct4 A and siOct4 B) cells 24 hr following OCT4 de
(D) Western blot assay showing expression of co-regulators in nuclear extracts 2
(E) ChIP-reChIP analysis of P300 and HDAC3 co-occupancy. The first ChIP was
were used for the reChIP.
(F) mRNA expression of the indicated genes in control versus Hdac3 KO cells as
See also Figure S3. *p% 0.05, **p% 0.01, ***p% 0.001,OCT4-depleted cells (e.g., Greb1l and Axin2) (Figure 5C), sug-
gesting that OCT4 can either negatively or positively control
signal-dependent enhancer activation.
To better understand how OCT4 regulates the activity of these
enhancers, first we confirmed, by enhancer reporter assays, that
the Hoxa1 +51 kb (activated by OCT4) and Greb1l 13 kb
(repressed by OCT4) regions are directly bound and regulated
by RAR:RXR (Figure S5B). ChIP-qPCR analysis revealed a dy-
namic recruitment of RAR and increased acetylation of the
Hoxa1 enhancer in control cells that was blocked by OCT4
depletion (Figure S5C). In contrast, the Greb1l 10 kb enhancer
showed increased H3K27ac in theOCT4-depleted cells, which is
in line with the observed higher eRNA production. These results
confirmed the enhancer-dependent effect of OCT4 in the regula-
tion of the signal response. RAR binding and acetylation of sites
independent of OCT4 (e.g., Cyp26a1 1.8 kb) were not altered
by OCT4 depletion (Figure S5D). OCT4 depletion also blocked
the CHIR99021-induced enhancer acetylation at theWNT/b-cat-
enin targets (Figure S5E).
To further dissect mechanistically how OCT4 and RAR:RXR
collaborate with each other, we cloned the Hoxa1 +51 kb
enhancer containing binding sites of both transcription factors.
As shown in Figure 5D, mutation of the OCT4 binding site re-
sulted in decreased RA response, strongly indicating the direct
requirement of both OCT4 and RAR:RXR for temporal (on-time)
and proper (the required amplitude) enhancer activation in early
differentiation. Indeed, we found that transcripts of various early
lineagemarkers (e.g.,Cxcr4,Gbx2,Sox17,Gata4,Stra8,Pmp22,
etc.) showed improper signal-dependent induction in OCT4-
depleted cells (Figures 5E and 5F; Figure S5F). However, RA-
mediated induction of the ubiquitously inducible Cyp26a1
proved to be OCT4-independent (Figure S5F).
Strikingly, we identified OCT4-occupied regions that were
co-occupied by both RAR:RXR and b-catenin upon activation
of WNT/b-catenin signaling. We chose Cdx1, a target for both
RA and WNT/b-catenin signaling pathways (Pilon et al., 2007),
for further analysis. In undifferentiated ESCs, Cdx1 showed
overlapping OCT4 and RXR binding in close proximity to the
Cdx1 TSS and recruitment of co-regulators (Figure 5G). Control
cells showed recruitment of b-catenin to the same OCT4/
RAR:RXR-occupied region, suggesting a to date uncovered
functional interaction between the two signal-dependent tran-
scription factors and OCT4 in the transcriptional regulation of
Cdx1. Loss of OCT4 inhibited both the RA- and CHIR99021-
dependent activation of this region (Figure 5H), indicating that
OCT4 is required for both the RA- and CHIR99021-dependent
induction of Cdx1. Co-treatment with RA and CHIR99021 re-
sulted in robust induction of Cdx1 gene expression (Figure 5I),
suggesting a synergistic effect of the two pathways in the regu-
lation of Cdx1.b1l 13 kb, Hoxa1 +5 kb, and Camk2n1 10 kb enhancers in control parental
pletion.
4 and 48 hr following the RNAi transfections.
carried out using anti-P300 antibody. Antibodies against IgG, HDAC3, or P300
determined by qRT-PCR.
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Figure 4. Signal-Dependent Redistribution of the OCT4 Cistrome
(A) IGV snapshot of RNA-seq data showing the Oct4 coding region. Cells were treated with RA for the indicated time points in 1 mM final concentration.
(B) Western blot analysis of OCT4.
(C) Density of OCT4 ChIP-seq reads relative to the midpoint (±1 kb). Cells were treated with 1 mM RA for 24 hr prior to the ChIP experiment. See also Table S3.
(D) IGV snapshot of enhancers representing ES-specific, constitutive, or RA-induced OCT4 binding.
(E) IGV snapshot of enhancers in the proximity of the Hoxa cluster.
(F) ChIP-qPCR detection of P300 enrichment at the Hoxa1 enhancer (+51 kb from the Hoxa1 TSS).
(G) qRT-PCR analysis of RA-induced eRNA production.
(H) ChIP-qPCR detection of OCT4 enrichment.
(I) De novo identification of motifs under ES-specific and RA-induced OCT4 sites using Homer (C). % target refers to the ratio of peaks having the givenmotif. See
also Figure S4.
*p% 0.05, **p% 0.01, ***p% 0.001.Hoxb1 Expression Is Controlled by OCT4
The results shown in Figure 3 suggested an interesting mecha-
nistic model; namely, that the pluripotency-specific transcription654 Molecular Cell 63, 647–661, August 18, 2016factor OCT4 drives co-regulator recruitment at lineage-specific
genes. Hoxb1 represents a unique example because binding
sites of OCT4 and RAR:RXR in its proximity are separated by
Figure 5. Dysregulated Signal Response in OCT4-Depleted Cells
(A) Read distribution heatmap of RXR or b-catenin ChIP-seq reads relative to the summits of the OCT4 peaks in the OCT4+/DNase low cluster (±1 kb). 283
OCT4+/DNase low genomic sites were occupied by RXR upon RA treatment, and 2724 sites were bound by b-catenin upon WNT activation. See also Table S4.
(B) IGV snapshot of enhancers representing RA or WNT/b-catenin target genes.
(legend continued on next page)
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Figure 6. OCT4-Dependent Co-regulator
Exchange on the Hoxb1 Enhancers
(A) IGV snapshot of the Hoxb1- and Cyp26a1-
coding genomic region.
(B) qRT-PCR analysis of Hoxb1 expression in
control parental and OCT4-depleted cells.
(C) ChIP-qPCR detection of H3K27ac enrichment
at the Hoxb1 0.2 kb enhancer depicted in (A).
(D) RA- or CHIR99021-dependent induction of the
target genes in doxycycline-inducible OCT4-
overexpressing HEK293T cells.
(E) IGV snapshot of OCT4 enrichment in the
proximity of HOXB1 (top) and AXIN2 (bottom) in
human ESCs. ChIP-seq data were used from
GEO: GSE21916.
(F and G) qRT-qPCR analysis of HOXB1 and
AXIN2 mRNA expression. Signal-dependent in-
duction of HOXB1 and AXIN2 was determined in
control or Dox-treated (inducible OCT4 expres-
sion) HEK293T cells. Cells were co-transfected
with RAR:RXR prior to RA addition.
See also Figure S6. *p% 0.05, **p% 0.01, ***p%
0.001.>1 kb. Hoxb1 has two retinoic acid response elements: RARE A
(located 1.6 kb from the TSS) and RARE B (+7 kb from the TSS
of the gene) (Marshall et al., 1994; Studer et al., 1994). These en-
hancers were bound by RAR:RXR upon RA stimulation but were
not co-occupied by OCT4 or any co-regulator at any time point
investigated (Figure 6A). However, we identified two additional
enhancers in the proximity of Hoxb1 that were occupied by
OCT4, termed ‘‘Oct4 A’’ (200 bp from the TSS) and ‘‘Oct4 B’’
(+9.3 kb from the TSS). Interestingly, the Oct4 B site showed
decreased OCT4 occupancy, whereas OCT4 was enriched at
Oct4 A following RA addition (Figure 6A). Remarkably, these
sites were also enriched for P300 and SMRT, and the co-regu-(C) qRT-PCR analysis of RA-induced (e.g., Hoxa1 +51 kb andGreb1l13 kb) and CHIR99021 (e.g., T/Bra0.
parental and OCT4-depleted cells. Twenty-four hours following RNAi transfection, cells were treated with RA (
(D) Enhancer reporter analysis of the Hoxa1 (+51 kb) enhancer. The 300-bp-long genomic region was clon
vector. Site-directed mutagenesis was carried out to modify the OCT4-binding site as shown. Retinoid-ind
transfecting these constructs into ESCs.
(E) Summary of lineage markers used in (F).
(F) Heatmap visualization of qRT-PCR analysis of lineage-specific marker genes by GENE-E (Broad Institute).
and OCT4-depleted cells were treated with 1 mM RA or CHIR99021 for 24 hr.
(G) IGV snapshot of OCT4, RXR, b-catenin, and the indicated co-regulator’s occupancy at the Cdx1 enhanc
(H) qRT-PCR analysis of Cdx1 expression in control parental and OCT4-depleted cells 24 hr after RA (blue)
(I) qRT-PCR analysis of Cdx1 mRNA expression 24 hr after RA, CHIR99021, or RA + CHIR99021 addition.
See also Figure S5. *p% 0.05, **p% 0.01, ***p% 0.001.
656 Molecular Cell 63, 647–661, August 18, 2016lator occupancy correlated with the
OCT4 movement (Figure 6A). Cyp26a1,
which showed OCT4-independent regu-
lation, was only enriched for RAR:RXR
(Figure 6A, right). Importantly, as a conse-
quence of OCT4 depletion, RA-depen-
dent induction of Hoxb1 was completely
abolished (Figures 6B and 6C). As shown
in Figures S6A and S6B, loss of OCT4 re-
sulted in decreased occupancy of SMRT
and HDAC3 at the Oct4 B enhancer in un-
treated cells, whereas P300 recruitment was also abolished at
theOct4 A enhancer in RA-treated, OCT4-depleted cells. Collec-
tively, these results reinforce the notion that OCT4 is required for
co-factor exchange.
To examine the biological relevance of co-repressor
recruitment during gene activation, we used HDAC3
knockout (KO) cells. Loss of HDAC3 selectively enhanced
the induction of Hoxb1 upon RA addition but did not change
the response of Cyp26a1 (Figure S6C). This suggests that
recruitment of HDAC3 has a negative compensatory function
upon gene activation and limits the amplitude of the signal
response.2 kb and Axin2 +41 kb) eRNA production in control
blue), CHIR99021 (green), or DMSO (black) for 3 hr.
ed into a thymidine kinase (TK)-luciferase reporter
uced activity of these elements was compared by
24 hr following RNAi transfections, control parental
er.
or CHIR99021 (green) addition.
Figure 7. Model of the Multi-level Cooperativity of OCT4, RAR:RXR,
and WNT/b-Catenin Signaling in Embryonic Stem Cells
Shown are identified recurring regulation patterns (Alon, 2007) in the OCT4-
controlled, RA-induced ESC program. In the pluripotent state, OCT4 con-
tributes to Rarg expression, and this receptor, along with RXRb, maintains the
expression of Lefty1 and Gbx2, forming a coherent feedforward loop. OCT4
also works as a repressor of lineage-specific genes (e.g., Hoxa1), but RA-
induced expression of HOXA1 feeds back on OCT4 levels (Martinez-Ceballos
et al., 2005), creating a double-negative loop in which the two factors repress
each other. Upon RA exposure, both OCT4 and the RAR:RXR dimer are
needed to activate the Hox cluster, suggesting that OCT4 and RAR:RXR are
integrated (AND gate) and contribute together to a graded retinoid response.
Similarly, activation of the canonical WNT signaling (e.g., T/Brachyury, Axin2)
also requires the presence of OCT4. Cdx1 represents an additional level of
cooperativity, integrating the RA and WNT/b-catenin signaling. Long-term RA
signal exposure leads to the induction of neurogenesis-related genes (e.g.,
Gbx2, Phox2b, Prmt8) (Chen et al., 2010; Dubreuil et al., 2000; Simandi et al.,
2015), whereas activation of the WNT signal induces primitive streak
commitment, represented by the induction of Axin2, Lef1, and T/Bra (Funa
et al., 2015; Rivera-Pe´rez and Magnuson, 2005).The identified collaboration between OCT4 and the signal-
dependent transcription factors RAR:RXR or b-catenin led us
to ask whether cell type-specific signal response is determined
by the lineage-determining factors (e.g., Hoxb1 gene induction
by RA is dependent on the presence of OCT4 in ESCs). To
address this, we introduced OCT4 ectopically into a human em-
bryonic kidney cell line (Figure 6D; Figure S6D). OCT4 could bind
to those sites in kidney cells in the proximity of HOXB1 that arealso OCT4-bound in human ESCs (Figure 6E; Figure S6E). Strik-
ingly, WNT/b-catenin and RA target genes, otherwise unrespon-
sive to these signals in kidney cells, showed induction following
overexpression of OCT4 (Figure 6F and 6G; Figure S6F and
S6G). CYP26A1 induction was OCT4-independent in this cell
type as well (Figure S6H). RA-mediated induction of HOXB1
eRNA in OCT4-overexpressing cells confirmed the OCT4-
dependent enhancer activation (Figure S6I). This set of experi-
ments provides a proof of concept that OCT4 is sufficient for line-
age-specific, signal-dependent transcription.
DISCUSSION
A key unanswered question in developmental cell biology is how
a cell type-specific enhancer set is selected during transition
from one cellular stage to another. This study addresses this
question, demonstrating the existence of an OCT4-dependent
priming step at signal-dependent enhancers prior to activation
of these loci. Based on our findings and previous work, we con-
structed a comprehensive model by combining recognizable
and stereotypical network motifs (Figure 7; Alon, 2007). This
model integrates several molecular connections clarified in this
study. First, it points out theOCT4-dependent positive regulation
of Rarg, a retinoic acid receptor isoform that has been shown to
be important in early retinoic acid response in ESCs (Al Tanoury
et al., 2014; Su and Gudas, 2008). Recent studies showed that
RARg has a critical role in cellular reprogramming (Wang et al.,
2011), and its genomic locus frequently interacts with the
OCT4 locus in human ESCs (Gao et al., 2013). Thus, accumu-
lating lines of evidence suggest that unliganded RARg is a regu-
lator of the pluripotent state and that its OCT4-controlled expres-
sion in the early stage of the cellular differentiation is essential for
retinoic acid-induced chromatin remodeling (Kashyap et al.,
2013). This conclusion is further supported by observations in
in vivo models showing very high expression of Rarg in the
caudal progenitor domain of late gastrulation stage mouse em-
bryos, where progenitor cells generate the posterior neural
tube (hindbrain and spinal cord) under the influence of RA syn-
thesis, which begins at embryonic day (E) 7.5 in presomitic
mesoderm (Cunningham and Duester, 2015).
Second, our proposed model posits that RAR:RXR shares a
subset of OCT4-occupied enhancers in the proximity of differen-
tiation-related genes. Previous studies already noted that OCT4
can bind at genes encoding developmental regulators (Boyer
et al., 2006; Loh et al., 2006; Yang et al., 2014). Our analyses
extended these results and demonstrate that an unexpectedly
large set of OCT4-occupied sites are located in low DNase
accessible chromatin regions and independent of the canonical
pluripotent network, potentially priming various cell fate-related
enhancers. The fact that loss of OCT4 causes deregulation of
RA andWNT immediate early genes suggests that OCT4 binding
at these sites has a mechanistic role in signal-regulated gene
expression and is not only an ‘‘innocent bystander.’’ Moreover,
the collaboration between OCT4 and RAR:RXR or OCT4 and
b-catenin is likely to be relevant in vivo at the very earliest stages
of embryonic development (E7.5–E8.5 in the mouse) when Oct4
is still expressed in the caudal progenitor domain (Osorno et al.,
2012). Indeed, Oct4 and Hoxa1 expression are co-localized inMolecular Cell 63, 647–661, August 18, 2016 657
E7.25–E9.25 embryos (Dupe´ et al., 1997; Perea-Go´mez et al.,
1999). The collaboration between OCT4 and RAR:RXR or
OCT4 and b-catenin is likely to require the presence of compos-
ite regulatory elements that contain two or more closely situated
binding sites for OCT4 and RAR:RXR/b-catenin and that provide
amechanism for crosstalk between the different regulatory path-
ways at the DNA-binding level. We present here the enhancers of
Hoxa1 +51 kb andCdx1 +1.1 kb as examples of such signal inte-
grating regions in ESCs.
A key question is the gene specificity of the interaction be-
tween the lineage-determining and signal-dependent transcrip-
tion factors (LDTFs/SDTFs). In other words, do all signal-regu-
lated genes require LDTF priming and direct binding to their
enhancers, or is it only restricted to a certain set? The latter ap-
pears to be the case. We show that, strikingly, the ubiquitously
responsive RA-degrading enzymeCyp26a1 is under OCT4-inde-
pendent control and is likely regulated by a distinct co-regulator
set independent of OCT4. This suggests that enhancer regula-
tion complexity was previously underestimated and that the
co-regulator complex composition can be enhancer-selective
(Krebs et al., 2011). In line with this, our previous study
demonstrated that cell type-specific transcription factors can
contribute to selective co-regulator recruitment (Simandi et al.,
2015) and that this recruitment allows the cells to selectively limit
the effect of external cues on target genes. This is important
because it forms the molecular basis of a tissue-selective reti-
noid response. By this mechanism, the signal-specific regulation
of developmentally important genes, such as Hox genes, is un-
coupled from ubiquitously retinoid-regulated transcriptional
events occurring in almost every cell type, such as Cyp26a1
(Ozpolat et al., 2005).
Simultaneous or co-binding enables OCT4 to act as a key
‘‘gatekeeper’’ of differentiation pathways providing cell type
specificity to the signal response. Re-appearance of OCT4 in
cells under pathophysiological conditions (e.g., cancer [stem]
cells) (Karoubi et al., 2009; Kumar et al., 2012; Wang et al.,
2013) may result in unwanted transcriptional events. Compari-
son of OCT4 ChIP-seq data in various cell types and manipula-
tion of OCT4 in these cells will be required to understand in
more detail how OCT4 changes the epigenomic status of cancer
stem cells or during cellular reprogramming.
In summary, our study highlights that OCT4 has multiple roles
and uncovers the mechanisms by which OCT4 plays essential
functions both in maintaining the ESC state and also in directing
subsequent differentiation by priming cell identity genes at the
level of enhancers and regulating co-factor binding. These
mechanisms might be applicable to other transitions during
cellular differentiation.
EXPERIMENTAL PROCEDURES
Additional methods, further details of the methods listed below, and related ci-
tations can be found in the Supplemental Experimental Procedures.
Cell Culture
Mouse E14 ESCs (termed ‘‘serum’’ or ‘‘‘naive’’ in the text) were cultured on pri-
mary mouse embryonic fibroblast (PMEF) feeder cells (5% CO2 at 37
C). ESC
medium was prepared by supplementing DMEM Glutamax (Gibco) with 15%
FBS (Hyclone), 1,000 U of LIF, penicillin/streptomycin, non-essential amino658 Molecular Cell 63, 647–661, August 18, 2016acids, and 2-mercaptoethanol. 2i ESCs were adapted for a minimum of five
passages to grow in serum-free N2B27-based medium supplemented with
LIF, PD0326901 (1 mM), and CHIR99021 (3 mM). Hoxa1 KO and appropriate
control cells were provided by the L.J.G. laboratory. HDAC3 KO cells were
supplied by the S.M.C. laboratory.
Ligands and Treatment
Cells were treated with vehicle (DMSO) or with the following ligands: all-trans
RA (Sigma, 1 mM stock in DMSO, 1/1,000 dilution) and CHIR99021 (Sigma,
3 mM stock in DMSO, 1/1,000 dilution).
siRNA Knockdown
Oct4 and control siRNAs were obtained from Thermo Fisher. Mouse E14 cells
were plated on gelatinized plates 12 hr before transfection. siRNA transfection
was carried out with Lipofectamine 3000 (Invitrogen). Transfected cells were
cultured in embryonic stem (ES) medium for 24 hr prior to experiments.
Primer Sequences
Sequences of primers used for cloning, mutagenesis, ChIP, and eRNA and
mRNA detection are available in the Supplemental Experimental Procedures.
ChIP-Seq, DNase-Seq, and ATAC-Seq Analyses
Primary analysis of the ChIP-seq raw reads was carried out using the ChIP-
seq analyze command line pipeline (Barta, 2011). Human OCT4 (GEO:
GSM545202), mouse OCT4 (2i + LIF) (Galonska et al., 2015), mouse NANOG,
KLF4, SSOX2 (GEO: GSE11431) (Chen et al., 2008), and b-catenin (GEO:
GSE43597) (Zhang et al., 2013) ChIP-seq data, assay for transposase acces-
sible chromatin sequencing (ATAC-seq) (GEO: GSM1563569) (Kearns et al.,
2015), and DNase sequencing (DNase-seq) data (GEO: GSM1014154 and
GSM1657364) (Consortium, 2012; Domcke et al., 2015) were downloaded
from the NCBI GEO database and re-analyzed.
ACCESSION NUMBERS
The accession number for the RNA-seq and ChIP-seq data reported in this pa-
per is SRA: PRJNA302640.
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